News

Adalimumab Promoted Mucosal Healing in Crohn's Disease

Publish date: April 12, 2012

 

FROM GASTROENTEROLOGY

This study was sponsored by Abbott Laboratories, maker of adalimumab. Dr. Rutgeerts and his associates reported numerous ties to industry sources.

Pages

Recommended Reading

Can a Biomarker Revive Everolimus for Advanced Gastric Cancer?
MDedge Internal Medicine
Hepatitis C Infection Increasing Among Adolescents, Young Adults
MDedge Internal Medicine
New Method of Gallbladder Drainage Safe, Effective
MDedge Internal Medicine
Children Most Vulnerable to Breakthrough Hepatitis B Identified
MDedge Internal Medicine
Anesthesia Services for GI Procedures Have Doubled
MDedge Internal Medicine
Gastroenteritis Deaths Soar, Largely Due to C. difficile, Norovirus
MDedge Internal Medicine
Risk Factors for C. difficile Recurrence Identified
MDedge Internal Medicine
Appendectomy Outcomes in Elderly Compared
MDedge Internal Medicine
Most People Told to Have a Colonoscopy Don't
MDedge Internal Medicine
Rising IPMN Incidence Traced to Increased Diagnostic Scrutiny
MDedge Internal Medicine